High performance random access kits
i-Tracker range associated with the i-Track 10 insrument is the Random Access solution for Therapeutic Drug Monitoring of Biologics
Accurate and Reliable
- Calibrated against WHO international standards
- Wide & dynamic measurement ranges
- CLIA technology bringing high performance
- Excellent correlation with LISA TRACKER reference kits
- Validated on originators and biosimilars
Fast
- Results in less than 40 minutes
- Fully automatable on the i-Track10 instrument
- Emergency function (STAT) at any time
- Cartridge of ready-to-use reagents
i-Tracker range
Contact us to learn more about the development of new products in the i-Tracker range.
| Reference | Designation | Intended Use | Packaging |
|---|---|---|---|
| CTA 002-100 | i-Tracker Adalimumab | Quantitative measurement of Adalimumab (anti-TNFα agent) in human serum or plasma samples | 100 tests |
| CTA 003-100 | i-Tracker Anti-Adalimumab | Quantitative measurement of Anti-Adalimumab antibodies in human serum or plasma samples | 100 tests |
| CTI 002-100 | i-Tracker Infliximab | Quantitative measurement of Infliximab (anti-TNFα agent) in human serum or plasma samples | 100 tests |
| CTI 003-100 | i-Tracker Anti-Infliximab | Quantitative measurement of Anti-Infliximab antibodies in human serum or plasma samples. | 100 tests |
| CTC 002-50 | i-Tracker Certolizumab | Quantitative measurement of Certolizumab (anti-TNFα agent) in human serum or plasma samples | 50 tests |
| CTC 003-50 | i-Tracker Anti-Certolizumab | uantitative measurement of anti-Certolizumab antibodies in human serum or plasma samples | 50 tests |
| CTG 002-50 | i-Tracker Golimumab | Quantitative measurement of Golimumab (anti-TNFα agent) in human serum or plasma samples | 50 tests |
| CTG 003-50 | i-Tracker Anti-Golimumab | Quantitative measurement of Anti-Golimumab antibodies in human serum or plasma samples | 50 tests |
| CTR 002-50 | i-Tracker Rituximab | Quantitative measurement of Rituximab (anti-CD20 agent) in human serum or plasma samples | 50 tests |
| CTR 003-50 | i-Tracker Anti-Rituximab | Quantitative measurement of Anti-Rituximab antibodies in human serum or plasma samples | 50 tests |
| CTU 002-50 | i-Tracker Ustekinumab | Quantitative measurement of Ustekinumab (anti-IL12/23) in human serum samples | 50 tests |
| CTU 003-50 | i-Tracker Anti-Ustekinumab | Quantitative measurement of anti-Ustekinumab antibodies in human serum or plasma samples | 50 tests |
| CTV 002-50 | i-Tracker Vedolizumab | Quantitative measurement of Vedolizumab (anti-α4β7 integrin) in human serum or plasma samples | 50 tests |
| CTV 003-50 | i-Tracker Anti-Vedolizumab | Quantitative measurement of anti-Vedolizumab antibodies in human serum or plasma samples | 50 tests |